MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…
  • 2017 International Congress

    The nature of postural tremor in Parkinson’s disease

    M. Dirkx, H. Zach, M. Hallet, R. Helmich (Nijmegen, Netherlands)

    Objective: To identify dopaminergic mechanisms underlying postural tremor in Parkinson's disease.  Background: Parkinson’s tremor classically occurs at rest, but many patients also have a postural…
  • 2017 International Congress

    Characterizing the Bcl-2 Associated Athanogene 5 Interactome

    E. Friesen, X. Wang, D. Williams, H. Chau, M. De Snoo, O. Pellerito, L. Kalia, G. Schmitt-Ulms, S. Kalia (Toronto, ON, Canada)

    Objective: Characterizing the Bcl-2 Associated Athanogene 5 (BAG5) interactome will uncover the molecular pathways with which BAG5 associates and further elucidate its role in dopaminergic…
  • 2017 International Congress

    Motor effects induced by D1- or D2-like receptor agonists in experimental parkinsonism.

    L. Andreoli, C. Alcacer, I. Sebastianutto, A. Cenci Nilsson (Lund, Sweden)

    Objective: We set out to compare movement patterns induced by systemic administration of l-dopa versus D1- or D2-class DA receptor agonists in mice with unilateral…
  • 2017 International Congress

    Altered somtatosensory cortex neuronal activity in a rat model of Parkinson`s disease and levodopa-induced dyskinesias

    K. Schwabe, X. Jin, J. Krauss, M. Alam (Hannover, Germany)

    Objective: In this study, we explored the neuronal firing activity of excitatory pyramidal cells and inhibitory interneurons in the forelimb region of the primary somatosensory…
  • 2017 International Congress

    Serum lipid profile in Parkinsons disease patients from Southern Spain

    C. Mendez Barrio, D. Macias Garcia, S. Jesus, M.A. Labrador Espinosa, L. Vargas Gonzalez, M. Bernal Escudero, A. Adarmes Gomez, F. Carrillo Garcia, M. Carvallo Cordero, P. Gomez Garr, P. Mir (Seville, Spain)

    Objective: Our first aim was to evaluate differences in the blood lipid profile levels between Parkinsons disease (PD) patients and healthy controls (HC). Secondly, in…
  • 2017 International Congress

    Phosphodiesterases and striatal pathways in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, A. Tziortzi, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: To use phosphodiesterase (PDE)10A ([11C]IMA107) and PDE4 ([11C]Rolipram) positron emission tomography (PET) molecular imaging combined with diffusion tensor imaging (DTI) based probabilistic tractography to explore the expression…
  • 2017 International Congress

    Plasma Biomarkers in Idiopathic Normal Pressure Hydrocephalus

    P.-W. Ko, K. Kang, S.Y. Kim, H.-W. Lee (Daegu, Republic of Korea)

    Objective: (1) To investigate the role of plasma biomarkers that is known to related to Alzheimer’s disease in INPH(2) To assess the diagnostic and prognostic…
  • 2017 International Congress

    Deferiprone combined with phlebotomy for aceruloplasminemia

    L.H.P. Vroegindeweij, J.G. Langendonk, J.H.P. Wilson, A.J.W. Boon (Rotterdam, Netherlands)

    Objective: To evaluate the efficacy and safety of chelation therapy with deferiprone combined with phlebotomy in reducing iron stores and neurological progression in aceruloplasminemia. Background:…
  • 2017 International Congress

    Perceptual decision making and reflection impulsivity in drug naïve and treated patients with restless legs syndrome

    B. Heim, M.-T. Pertl, A. Stefani, A. Heidbreder, L. Zamarian, E. Brandauer, B. Averbeck, M. Delazer, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective:  To investigate perceptual decision making and reflexion impulsivity in patients with restless legs syndrome (RLS) with and without dopamine replacement therapy.  Background:  Detailed neuropsychological…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley